home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  December 13, 2019
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 525 active entries

SOYUS

An SBO Company
Canada
Canada
Toll free: +011-604-941-9022 (help line)

Phone: +011-604-945-8408 (local)
Fax: +011-604-941-9022 (FAX line)
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

We are predicting the growing trend now and in future to soy crops especially in Australia and developments there of a possible techie cluster originating in Queensland Australia as a geographical landscape is already described as an American-invested project - wheat crops (food and FCR feed & energy fuel feedstock) and rapeseed & jatropha (oilseeds for feed and biodiesel fuel).

While in Kazakhstan, a Canadian-Russian investment in energy derivatives using straw and higher alcohols by microbial fermentation using cutting-edge microbial engineering, grain (biodiesel and wax cutins) (see: UBC current literature) and marine seagrass using their leaves and roots sectioned for biodiesel and polyaliphatics (biokerosene, of C6-C16) (a major investment for future aerospace travel) also known by the name project Genus which has been also proposed by SkyeBlue for the Philippine Islands.

The use in countries like Kazakhstan led by the Canadian-Russian consortium is predicted to go ahead with the seagrass affair using local bodies of water with mined salt reserves with its exceptional availability for feed, food and energy and much better quality in its ligno-cellulose component. One recent study earmarked the use of large facilities and attributed the cost of processing feed byproducts to about half and stated it was due to the quality and the large quantities handled and the time of fermentation, including sterilization, to make it economically feasible necessitating more expensive heavy equipment to handle. We believe that based on these findings that major research studies are expected due to: their higher quality, albeit, additionally a cutting and drying process is required and the highly regulated flow-process type set up for the physical plant- which will be in part paid for by the high added-valued major product of pharma feedstock vs feedstock for food and energy. 

SKYEVIEW: In the future, the miracle of Philippine development is shaping up to be another opportunity to launch off initiatives to further areas out in C. Asia, rest of SE Asia and the Asian & Russian Far East in terms of technology transfer liaison and investments from foreign sources and the spreading co-op movement like in the Philippines.  The Philippines will benefit from its milieu of maturating democratic systems and a more open and stabler free enterprise systems, competitiveness based on capitalistic values and, hopefully what will be a corrupt-free, meritorious value system. 

SKYEVIEW: Now in C. Asia there are outstanding issues in development planning that need addressing especially with increased urbanization or density: 1) Law & Order Enforcement - Community Engagement & Civic Duty with training and provision of jobs for members of the populace, 2) Population Control - developing population control policy (1-child policy) put in place, 3) Banking & Investments with Financial Markets including: Venture Funds, Government bonds, Brokers & Financiers and Banks for Accounts & Investments, 4) Commuting and the Issue of Vehicular transport, roads and bridges infrastructure construction and 5) Tourism (e. g. BnB's, Airports, Commuters, Hotels, Resorts, Parks & Recreation). 



Selected Categories:
Product Company   Service Company
Consulting
- General
Contract
- Services
Professional
- Communications

Last update of this entry: August 05, 2019

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.